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Introduction 
This systematic review aims to review the current literature to compare 
depression patients with psychogenic non-epileptic seizures (pwPNES) with that in 
patients with epilepsy (PWE) in order to establish if there are differences in the 
prevalence and presentation of depression between these patient groups.  
PWE frequently experience co-morbid psychiatric disorders. Mood disorders 
(including major depression) are the most common with a prevalence of 
24.4%/14.1% (lifetime/past year) in PWE, as compared to 13.2%/5.2% in the general 
population [1]. Similarly, co-morbid psychiatric disorders are more common in 
pwPNES than in the general population and again, depression is the most common 
psychiatric disorder with an average prevalence of 31% and lifetime rates ranging 
from 36-80% [2]. 
The presence of depression is associated with worse outcomes in both 
patient groups. In PWE there is an association between depression and seizure 
frequency [3]. This relationship is one of the manifestations of the bidirectional links 
between depression and epilepsy [4, 5, 6, 7]. Whilst elevated levels of depression 
could reflect the negative impact of seizures, Lehrner et al. [8] found depression was 
a significant predictor of health-related quality of life (HRQoL), even after controlling 
for seizure frequency. It is possible a similar bidirectional relationship also exists for 
pwPNES as depression has been found to predict the level of dysfunction 
experienced by these patients [9]. Supporting a possible causative effect, one study 
[10] found that treating pwPNES with sertraline (an anti-depressant) reduced seizure 
rates compared to a placebo group which reported an increase in seizure frequency 
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during follow-up (although in the absence of sufficiently powered studies, it is not 
clear that antidepressant treatment for pwPNES can currently be recommended in 
the absence of evidence of co-PRUELGGHSUHVVLRQRUDQ[LHW\´ 
Several reviews have explored depression in PWE e.g. [9], however, less has 
been written about depression in pwPNES. Most only discuss the latter topic in 
passing or lack detail)RULQVWDQFH.DQQHUHWDO¶V[9] review of depression in PWE, 
contrasted depression scores in PWE and pwPNES, with pwPNES having higher 
depression scores. However, the search and quality assessment method were not 
described and group differences were not statistically assessed. A recent systematic 
review [11] of depression in pwPNES found that pwPNES have higher levels of 
depression than PWE, although this difference was not statistically significant. 
However, this review focussed on clinically diagnosed depression and excluded 
studies using self-report measures of depression. Only seven studies met their 
criteria, reducing the power of the analysis and possibly explaining why the 
difference between the groups was not significant.  
Interestingly, Kanner et al. [9] suggested that the interplay between peri-ictal 
symptomology and depression, along with the high co-morbidity between depression 
and anxiety in PWE means that depression can present atypically in this population. 
In a similar vein, Diprose et al. [11] suggest that pwPNES often present with somatic 
symptoms rather than psychological distress. Differences in the manifestation of 
depression could have implications for how depression is identified and treated in 
these patient groups, but no previous reviews have explored the phenomenology of 
depression in both of these common seizure disorders.  
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As such, this article intends to provide a systematic review of the existing 
literature comparing epilepsy in PWE and pwPNES in a two stage process: Stage 
one focuses on prevalence by conducting a meta-analysis comparing levels of self-
reported and clinically diagnosed depression in patients with these two seizure 
disorders. Stage two explores differences in the phenomenology of depression by 
comparing depressive symptoms and associated factors in PWE and pwPNES. 
 
Method 
The methodology for this review was informed by the preferred reporting 
items for systematic reviews and meta-analysis (PRISMA) statement [12]. 
Literature Search 
To capture relevant studies, a search was run on ScienceDirect and Web of 
Science, on 29/01/2017. The search scanned the title-field for terms relating to 
PNES and all-fields for terms relating to depression, using the following terms: 
TITLE: ((nonepilep*) OR ({non-epilep*}) OR (pseudoseizure$) OR ({pseudo-
seizure$}) OR (pseudoepilep*) OR ({pseudo-epilep*}) OR (dissociative adj seizure$) 
OR (dissociative adj convulsion$) OR (hysterical adj seizure$) OR (hysterical adj 
convulsion$) OR (hysteroepilepsy) OR ({hystero-epilep*}) OR (conversion adj 
seizure$) OR (psychogenic adj seizure$) OR (functional adj seizure$)) 
AND 
ALL FIELDS: (depress* OR psychopatholog* OR psychiatric OR psycholog*) 
No time limits were used in the search. The systematic search was complemented 
by a search of the reference lists of identified publications. 
Article Screening 
 5 
Papers were required to be written in English and to describe comparative 
studies involving separate epilepsy and PNES samples. Abstracts were screened for 
key words relating to depression, psychiatric/psychological disorders or measures of 
depression. Because of likely differences in the aetiology of epilepsy and PNES 
between paediatric and adult populations as well as between patient groups with and 
without intellectual disabilities (ID), papers were excluded if the samples contained 
individuals aged 15 and under, or focussed on ID. We also excluded papers 
predominantly describing neurological issues, EEG or medication. During full text-
analysis, studies were excluded if they did not explicitly report depression 
scores/prevalence for each patient group and statistically compare these (although 
statistical comparisons were not required for the prevalence of depression).Studies 
ZHUHDOVRUHTXLUHGWRKDYHD31(6VDPSOHLH!SRZHUWRGHWHFWDYHU\
large effect size). 
Papers meeting these criteria were included in the analysis of prevalence. 
Papers used in the phenomenological comparison were also required to either 
include further analysis of depression measure subscales, or further analyses of 
depression scores (e.g. correlations or regression analyses). 
Several papers used overlapping samples across multiple manuscripts and 
were excluded from the review. Whilst [13] and [14] used related samples, the level 
of overlap was unclear and figures from both papers were included, although [14] did 
not report the Beck Depression Inventory-II (BDI-II) [15] figures and so this measure 
was excluded. Studies [16, 17, 18 and 19] also used a shared dataset and [16] was 
excluded as it appeared to reflect an earlier stage of recruitment to [17]. Different 
sample sizes and measures in papers [17, 18 and 19] mean that all were included, 
although the Profile of Mood States (POMS) [20] reported by [19] was excluded as 
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other studies reported this using larger samples of pwPNES. The overall process is 
shown in Figure 1. 
 
Figure 1. PRISMA Diagram. 
Statistical Analysis 
Where possible, the magnitude of the difference in depression scores 
EHWZHHQSZ31(6DQG3:(ZDVPHDVXUHGXVLQJ&RKHQ¶Vd effect size [21]  and 
Database search   
ScienceDirect: n  = 464   
Web of Science: n  = 552   
Total: n  = 1,016   
Reference list search   
n 
 = 31   
Title screening   
n 
 = 932   
Abstract screening   
n 
 = 365   
Full paper screening   
n 
 = 81   
Duplicate screening   
n 
 = 1,047   
Duplicates removed   
n 
 = 115   
Studies used in the   
phenomenological comparison   
   
n 
  
= 12 
  
Studies used in the prevalence comparison   
n 
 = 34   
Records excluded   
n 
 = 567   
Records excluded   
n 
 = 284   
Records excluded   
n 
 = 47   
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calculated with Comprehensive Meta-Analysis (CMA; Version 3.3.070) [22]. An effect 
size of d ZDVXVHGWRLQGLFDWHDVLJQLILFDQWGLIIHUHQFHEHWZHHQWKHSDWLHQW
groups. This was based on the minimum cut-off score recommended to indicate a 
practical significant effect (i.e. likely to indicate a practically meaningful difference 
between the groups) for social science data [23].A random-effects meta-analysis 
was run using CMA. Publication bias was assessed using rank correlation with 
.HQGDOO¶VWDX [24], fail-safe N [25] and funnel plots including a trim and fill analysis 
[26]. 
Reported prevalence figures of depression were compared using a two-tailed 
independent t-test on the Statistics Calculator (Version 4.0) [27].  
Quality Appraisal Tool 
Few quality appraisals have been developed specifically for research focusing 
on PNES. Although generic appraisal schemes exist, these do not assess the validity 
of the diagnostic process used to differentiate PNES and epilepsy. One measure 
designed specifically to evaluate research on pwPNES [28] assesses methodology 
using seven criteria (Appendix A):  
1. Was diagnosis based on video-EEG documentation of typical seizures? 
2. Was epilepsy excluded from the PNES sample? 
3. Were attacks distinguished from anxiety attacks? 
4. Was recruitment consecutive? 
5. Were dependent variables standardised? 
6. Were comparison groups demographically comparable to the PNES 
VDPSOH\HDUVDJHGLIIHUHQFHDQGGLIIHUHQFHLQWKHQXPEHURI
females)? 
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7. Were PNES excluded from comparison groups?  
A score of 0-1 is calculated by dividing the number of achieved criteria by seven. The 
sample size is scored using the following criteria: good (n PRGHUDWHn = 26-
63), or poor (n = 15 - 25). The methodology and sample appraisals are combined to 
GHWHUPLQHWKHRYHUDOOVWXG\TXDOLW\KLJKVFRUHDQGDJRRGVDPSOHVL]H
PHGLXPVFRUHDQGDPRGHUDWHVDPSOHVL]Hor score = 0.50 - 0.79 and a good 
or moderate sample size), low (score = 0.20 - 0.49, or a poor sample size), or 
unacceptable (score < 0.20). To determine the accuracy of the appraisals, a second 
researcher evaluated the papers using the same criteria. 
 
Results 
Quality Appraisal 
The inter-rater agreement for the quality appraisal was 90.8%. Of the 34 
papers reviewed, 22 were rated as low quality and 12 were rated medium quality 
(see Appendix B for a full summary). The predominant factor leading to the relatively 
low quality ratings was a small sample size. Most studies (n = 29) used a poor or 
PRGHUDWHVDPSOHDQGRQO\ILYHKDGDJRRGVDPSOHVL]HSDUWLFLSDQWVSHUJURXS 
Excluding the sample size criteria, methodological procedures were rated 
more favourably, with nine rated low quality, 24 medium quality, one high quality and 
a mean methodological quality of 0.6. The most common shortcomings were the 
failure to state how PNES and anxiety were differentiated or to use samples with 
sufficiently similar age and gender distributions. Of these, the failure to explain how 
PNES were distinguished from anxiety attacks is most detrimental as anxiety is an 
important diagnostic confound in PNES [29]. Additionally, only 23 studies used 
video-EEG for all diagnoses, the gold standard diagnostic method for PNES [30]. 
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These limitations make it more difficult to be confident that PNES had always been 
diagnosed correctly. 
Depression Measures 
A total of 46 measures of depression, including self-report measures and 
clinical diagnoses were used in the different studies identified. At least one well-
validated measure of self-reported depression was used in 13 of the studies 
reviewed. The BDI-I and BDI-II have been particularly well-validated, including for 
use in epilepsy [31]. The Patient Health Questionnaire-9 (PHQ-9) [32] and Hospital 
Anxiety and Depression Scale (HADS) [33] are well-validated generic screening 
tools for depression [34, 35] and have been validated in PWE [31]. The Depression 
Anxiety Stress Scale (DASS) [36] has been validated in clinical populations [37], 
although it has not been validated within an epilepsy population. Finally, the 
Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) [38] was 
developed specifically for use in PWE and has been validated for use in pwPNES 
[39], although only as a categorical measure designed to identify patients likely to 
have current major depression, rather than a scaled measure.  
However, 15 papers did not use clearly validated measures of depression. In 
this review, most studies of this nature used the depression scales of the Minnesota 
Multiphasic Personality Inventory (MMPI)-1 [40], MMPI-2 [41] or Personality 
Assessment Index (PAI) 426]. These measures were developed as assessments of 
personality. Therefore, they have significant limitations as screening tools for 
depression, particularly the MMPI, which was developed based on historical 
constructs of psychopathology that are no longer valid [43]. Whilst the PAI was 
designed around modern clinical diagnoses [42], only moderate evidence was found 
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of convergent validity between the PAI depression scale and a diagnosis of major 
depression [44].  
Other studies used the POMS depression/dejection and Brief Symptom 
Inventory (BSI) [45] depression scales. It is equally unclear how valid these 
measures are as screening tools for depression. The factorial structure of the BSI is 
unclear [46], and the POMS depression/dejection scale has poor discriminant validity 
between depression and anxiety [47]. 
Of the studies reviewed, nine reported rates of clinically diagnosed 
depression, although two of these did not specify the diagnostic criteria used. The 
remaining seven studies used the diagnostic and statistical manual (DSM) criteria, 
either the DSM-III [48], DSM-IV [49] or DSM-IV-TR [50]. Four of these studies 
diagnosed depression using the Structured Clinical Interview for Axis-I Disorders for 
DSM-IV, Clinical Version (SCID-CV) [51], widely considered as the gold standard 
diagnosis tool for psychiatric disorders [52]. 
Comparison of Depression Levels in PwPNES Compared to PWE 
The majority of measures (42 of 45, 93.3%; one measure did not report 
figures) reported in the studies found pwPNES had higher levels of depression than 
PWE, although this difference was only significant in 32.6% of analyses (see 
Appendix C for all results). In all comparisons where effect sizes could be calculated 
(n = 29), pwPNES scored higher on self-report measures of depression than PWE, 
with 58.6% of these exceeding d = .41 and indicating a practically significant 
difference (Figure 2).  
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Figure 2. Box-and-whisker plot of effect sizes indicating the magnitude of difference 
in depression scores between PWE and pwPNES. 
 
 
A meta-analysis was conducted on studies using well-validated measures 
(BDI-I/II, PHQ-9, HADS, DASS and NDDI-E; N studies = 13, N participants = 1,366). 
The median quality of these 13 studies was low (n = 11), with two medium quality 
studies. There was no correlation between the quality of the study and the effect size 
reported, Ĳ(N = 13) = .10, p = .69, Effect sizes were homogenous Ȥ2 (12) = 10.14, p 
= .60 and a significant overall effect size was found indicating a practical difference 
in levels of depression between the groups, d = .51 (95% CI [.40 - .62]), z = 8.93, p 
<.001, There was no evidence of publication bias, with a fail-safe N = 206. The Begg 
and Mazumdar rank correlation was non-significant, Ĳ(N = 13) = -.04, p = .85. The 
funnel plot can be seen in Figure 3, with a point estimate of .51 (95% CI [.40 - .62]) 
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which was unchanged following the Trim and Fill analysis. These findings suggest 
that the finding that pwPNES report higher levels of depression than PWE is robust. 
Figure 3. )XQQHOSORWRIVWDQGDUGHUURUDJDLQVW&RKHQ¶Vd. 
This highlights an interesting discrepancy. Despite pwPNES self-reporting 
higher levels of depressive symptoms, only one paper reporting on clinical diagnoses 
found a significant difference between PWE and pwPNES. It was possible that the 
scores in pwPNES were still predominantly below clinical levels. To explore this, the 
nine studies reporting on clinically diagnosed depression were compared to the six 
studies which used clinical cut-off scores on self-report measures of depression. The 
mean prevalence rates (Figures 4a and 4b- NB [14] did not report figures, and could 
not be included in this figure) show that whilst rates were comparable in PWE, more 
pwPNES reported depressive symptoms suggesting higher rates of clinical 
depression than were diagnosed (or excessive symptom reporting on self-report 
scales). However, it is important to note that this difference was not significant, 
although only a small number of studies could be included in this comparison. 
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Figure 4a. Forest plot of self-reported levels of clinical depression and diagnosed 
clinical depression in pwPNES. 
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Figure 4b. Forest plot of self-reported levels of clinical depression and diagnosed 
clinical depression in PWE. 
 
 
Comparison of Factors Associated with Depression in PwPNES and PWE 
For supplementary data tables for this narrative synthesis section, please see 
Appendix D. 
Depressive symptomology. Five studies analysed subscales of the PAI and 
MMPI depression scales. The PAI depression scale contains three subscales, Dep-C 
(cognitive symptoms e.g. poor concentration or thoughts of helplessness), Dep-A 
(affective symptoms e.g. sadness or loss of interest in activity) and Dep-P (physical 
symptoms e.g. sleep disturbance or physical functioning). PwPNES consistently 
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scored higher than PWE and significant differences were found on all subscales 
(Table 1).  
Table 1 
Comparisons of statistically different PWE and PNES scores on subscales of the PAI  
Study  Dep-A Dep-C Dep-P 
Asmussen et 
al. [53] 
PNES / PWE mean   61.3 / 55.7 
Difference   5.6 
Effect size (d) 
  .48** 
Gale et al. 
[54] 
PNES / PWE mean 58.7 / 52.6 57.8 / 54.2 66.6 / 56.3 
Difference 6.1 3.6 10.3 
Effect size (d) .49*** .28** .88*** 
Thompson et 
al. [55] 
PNES / PWE mean  61.4 / 57.7 67.7 / 59.1 
Difference  3.7 8.6 
Effect size (d) 
 .29* .76*** 
Wagner et al. 
[56] 
PNES / PWE mean   69.4 / 56.9 
Difference   12.5 
Effect size (d) 
  Unknown* 
Shaded cells indicate non-significant group differences 
* p < .05 
** p < .01 
*** p < .001 
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All studies found that pwPNES reported significantly more physical difficulties 
than PWE (Dep-P). In contrast, only 50% of studies found significant differences in 
cognitive aspects of depression (Dep-C), although the studies revealing significant 
differences had better sample sizes and methodological quality, and thus greater 
power to detect an effect. Findings on affective aspects of depression (Dep-A) were 
less equivocal, as only one study (with the largest sample size) found a significant 
result. Although pwPNES scored higher than PWE, mean scores did not indicate 
clinical levels of difficulty except on the Dep-P subscale which indicated a mild 
difficulty. Contrary to PAI findings, [57] found no significant differences on any of the 
depression subscales of the MMPI-2 including D3 (physical malfunctioning), 
although the previously discussed weakness of the MMPI-2 (e.g. outdated constructs 
of psychopathology) could account for these differences. 
A possible explanation of the group differences on the Dep-P subscale of the 
PAI could be the higher proportion of females in the PNES samples. Females with 
PNES reported significantly higher scores on this subscale than males with PNES 
[53, 54]. In summary, these findings suggest that pwPNES, especially females, 
suffer from, or recognize, the physical symptoms of depression more than the 
cognitive and emotional aspects.  
Attachment, relationships and depression. Several studies investigated 
depression in conjunction with aspects of interpersonal functioning. Green et al. [58] 
explored the association between attachment and depression in PWE and pwPNES, 
focusing on the relationship with the main caregiver. They found relationship conflict, 
attachment, attachment anxiety and attachment avoidance significantly correlated 
with depression in both patient groups. Although all these correlations were stronger 
for pwPNES, the only significant group difference was in attachment anxiety, where 
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pwPNES showed a significantly stronger positive correlation between attachment 
anxiety and depression. Relationship variables explained a significant proportion of 
depression in both patient groups, although these only accounted for 16% of the 
variation in PWE, compared to 45% of the variation in pwPNES. Seizure and 
demographic variables were more comparable between groups, explaining 26% of 
variation in pwPNES and 23% in PWE, although this association was only significant 
in PWE. Interestingly, whilst seizure severity was a significant predictor of 
depression in patients with PWE, this was not the case for pwPNES. These findings 
all suggest that depression in pwPNES is more closely related to relationship factors 
than illness-related factors, whilst the opposite pattern is true for PWE.  
A caveat for interpreting this study is the large difference in the population 
sample sizes, with a PNES sample of 23 compared to a PWE sample of 72. This 
may explain why the proportion of depression accounted for by seizure and 
demographic variables was only significant in PWE, despite accounting for more 
variation in depression scores in pwPNES.  
Another study which examined the link between depression and interpersonal 
factors in PWE and pwPNES was LaFrance Jr. et al. [59], who analysed the 
association between family functioning and depression, although the study focused 
on HRQoL (see next section). Family functioning was found to be unhealthy for both 
PWE and PNES. However, only in pwPNES was family functioning significantly 
correlated with depression scores, along with family affective involvement (e.g. 
valuing each other) and roles (the patterns of behaviour used to fulfil family 
functions). This suggests that family functioning may have a stronger association 
with depression in pwPNES, complementing the findings of Green et al. [58] and 
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suggesting there is a closer association between relationship variables and 
depression in pwPNES than in PWE. 
Health status, quality of life and depression. As part of the previously 
described study, LaFrance Jr. et al. [59] analysed HRQoL, exploring its relationships 
with depression and seizure-related variables. They found a significant relationship 
for both patient groups, with depression explaining 46% variation in HRQoL PNES 
and 40% in PWE, more than that explained by seizure frequency, illness duration, or 
family functioning.   
In contrast, Karakis et al. [60] found depression to be a significant determinant 
of HRQoL in pwPNES, but not in PWE. This is a surprising finding, given the strong 
relationship reported between HRQoL and depression in PWE [61]. This contrasting 
finding by LaFrance Jr. et al. [59] and Karakis et al. [60] may reflect the analyses 
used by Karakis et al., with only significant group differences being entered into the 
regression analysis.  
Another study assessing HRQoL [62] found highly significant correlations 
between HRQoL and depression in both patient groups, with depression again 
explaining more variance in HRQoL scores than seizure-related variables in both 
patient groups. Although some participants were recruited from a hospital, this was 
one of the few studies which also recruited from a non-medical setting, suggesting 
the findings can be generalized beyond the clinical environment.  
J. Szaflarski and M. Szaflarski [18] also explored the relationship between 
HRQoL and depression. They used the 36-item Short Form Health Survey [63] which 
contains 8 subscales; physical functioning, role limitation: physical, role limitation: 
emotional, energy/fatigue, emotional well being, social functioning, pain and general 
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health. Using a POMS cut-off score of >12 to indicate depression, they found 
depressed pwPNES reported significantly lower HRQoL across all SF-36 subscales 
WKDQGHSUHVVHG3:(7KHDXWKRUVFRQGXFWHGIXUWKHUDQDO\VHVRQWKHµUROHOLPLWDWLRQ
SK\VLFDO¶VXEVFDOHFRPSDULQJGHSUHVVHGPWE and pwPNES with clinically 
depressed patients. After controlling for multiple comparisons, they found that 
depressed pwPNES reported significantly lower scores on this subscale than 
clinically depressed patients, a pattern not found in PWE. This supports the earlier 
findings that depression in PNES is more strongly related to physical symptoms of 
depression. Unfortunately, the use of the POMS is a weakness as it has no 
standardised clinical norms. 
In summary, these findings highlight a strong, positive relationship between 
depression and HRQoL in both pwPNES and PWE. It may be that depression has a 
greater influence on HRQoL for pwPNES than in PWE, but this difference is 
marginal. Again, the strongest relationships with depression appear to be with the 
physical rather than emotional aspects of HRQoL in pwPNES. 
Cognitive and emotional functioning and depression. Two papers 
explored the links between depression and emotional or cognitive function in PWE 
and PNES. Prigatano and Kirlin [64] investigated subjective and objective measures 
of affective and cognitive functioning in PWE and PNES, using the PAI to assess 
psychopathology. Notably, the study found that pwPNES subjective reports of 
depression had significant large and medium positive correlations with subjectively 
reported cognitive difficulties and a standardised test of delayed memory. In contrast, 
the standardised measure (the PAI-depression scale) correlated with subjective 
memory abilities, but no other subjective or standardised cognitive measures. 
However, this study provided little detail about the methodology, diagnostic process, 
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or analytical methods used and did not adjust the significance level for the high 
number of correlations tested. This creates a strong likelihood of Type-I error, further 
compounded by the small sample size. 
A more robust study of emotional functioning was completed by R. Brown et 
al., [65] who clustered PNES patients based on their scores on measures of 
emotional dysregulation and alexithymia. This identified two patient clusters, one 
with high emotional dysregulation and alexithymia scores (cluster one) and the other 
containing the remainder of the PNES sample (cluster two). Analysis of PHQ-9 
scores found both clusters had significantly higher levels of depression than PWE, 
but no significant differences were found between the two clusters of pwPNES. 
Although clustering patients allowed an interesting analysis of depression in 
pwPNES, it reduced the sample sizes, limiting the power of analyses. This could 
explain why no significant difference was recorded between PHQ-9 scores in 
clusters one and two, despite having a larger discrepancy between means than 
cluster two and PWE.  
 
Discussion 
The studies identified in this review consistently found that pwPNES report 
higher levels of depressive symptoms than PWE. In the majority of studies, this 
difference was not significant; however this appears to be related to the low quality of 
most studies which were based on small samples and had low statistical power. Our 
meta-analysis confirmed the finding of higher levels of depression in pwPNES, 
identifying a significant and practical difference in depression levels between PWE 
and pwPNES. Despite pwPNES reporting higher levels of depressive symptoms than 
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PWE, this was not reflected by the rates of clinical diagnoses of depression. 
Although overall rates of diagnosed depression were higher in pwPNES than for 
PWE, there was a greater discrepancy between the rate of clinical diagnosis and 
self-reported clinical levels of depression than that seen in PWE. It was not clear 
from the studies reviewed what caused this discrepancy. Possible explanations 
include the under-diagnosis of clinical depression in pwPNES, or pwPNES 
catastrophising symptoms on self-report measures. 
Supporting the hypothesis that depression has a specific profile in those with 
PNES, Wagner et al. [56] suggested that pwPNES do not show the spectrum of 
symptoms typically associated with clinical depression. This is supported by the 
consistent finding that compared to PWE; pwPNES are more likely to highlight the 
physical symptoms of depression than cognitive or emotional aspects. This may 
mean clinicians overlook patient reported symptoms of clinical depression. 
Additionally, many formal diagnostic methods (e.g. the SCID) are based on an 
etiological model which excludes symptoms that could be attributed to a known 
medical condition [66]. Due to the physical symptoms associated with PNES, 
epilepsy, or the treatment of these disorders, it is possible clinicians do not prioritise 
patient reports of physical symptoms of depression, potentially leading to missed 
diagnoses. Whilst conventional diagnostic criteria (e.g. the DSM) apply to many 
PWE, they may poorly reflect some of the atypical features of depression seen in this 
population [9]. The current findings would suggest this is even more applicable for 
pwPNES. 
Another potential explanation for the discrepancy in rates of clinically 
diagnosed depression and self-reported symptoms is that pwPNES catastrophise 
symptoms of depression and rate these as more severe than may appear to 
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clinicians. Catastrophising is defined as an exaggerated set of negative cognitions 
which magnify anticipated or perceived threat [67]. Supporting the idea that 
catastrophising could explain the elevated self-reported depression symptoms seen 
in pwPNES, pwPNES have been found to experience emotions as more 
overwhelming, report more severe somatic symptoms and interpret these as more 
threatening than PWE [68]. Evidence of a tendency for pwPNES to catastrophise 
(and for PWE to normalise) potentially distressing symptoms has also been provided 
by a study examining how patients describe their seizures to a doctor [69]. 
The findings of this study add to the large evidence base that pwPNES 
express distress somatically and report more somatic symptoms than PWE [70, 71, 
72, and 73]. Despite this finding, it is important to note that in some studies, pwPNES 
also reported higher scores on measures of affective and cognitive aspects of 
depression than PWE. Additionally, the fact that pwPNES self-report higher levels of 
depression than PWE suggests an awareness of emotional experience, with this 
awareness recorded even in pwPNES with high alexithymia scores [65].  
Several factors relating to interpersonal functioning were significantly 
associated with depression in pwPNES. Green et al. [58] found that relationship 
YDULDEOHVH[SODLQHGRIWKHYDULDWLRQLQSZ31(6¶GHSUHVVLRQVFRUHVZLWK
anxious attachment scores having particularly strong positive associations with 
depression. This relationship was found in both pwPNES and PWE, supporting the 
idea that a fearful attachment style is associated with higher depression scores [74]. 
However, the relationship between attachment anxiety and depression was stronger 
in pwPNES than PWE, suggesting the link is closer in those with PNES than might 
typically be expected. This finding is likely to be clinically relevant as pwPNES 
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typically have higher levels of fearful attachment [75], suggesting this may be a key 
factor in the levels of depression observed. 
The importance of relationship factors was supported by LaFrance Jr. et al. 
[59] who found that measures of family functioning, whilst unhealthy in both PWE 
and pwPNES, only significantly correlated with depression in pwPNES. This matches 
the findings of Krawetz et al. [76], who found pwPNES perceived their families as 
dysfunctional, particularly in areas of communication and emotional involvement. 
Krawetz et al. argue this suggests pwPNES may struggle to articulate their needs 
and feelings within the family system. Being unable to effectively resolve conflict with 
family members, combined with an anxious or fearful attachment style, could cause 
depression. Whilst it is not possible to determine cause and effect from these 
studies, it has been found that supporting pwPNES to address family discord lead to 
a subsequent reduction in depressive symptoms [77], suggesting a potential 
causative relationship.  
Whilst seizure-related variables (e.g. seizure severity) had a stronger 
relationship with depression scores in PWE than pwPNES, the relationship between 
the impact of health status on life (as assessed by HRQoL measures) and 
depression was less clear cut. The findings suggest that the influence of health 
within DSHUVRQ¶VOLIHKDVDVOLJKWO\VWURQJHUUHODWLRQVKLSZLWKGHSUHVVLRQLQ pwPNES 
than PWE. However, in both patient groups, depression explained more variation in 
HRQoL than seizure-related variables [59, 62] and family functioning [59]. This 
highlights the impact of depression in both patient groups, although again, the cross-
sectional nature of the studies reviewed meant that the direction of this relationship 
cannot be determined. As HRQoL incorporates psychological health, it is fair to 
assume that depression has a causative impact on this construct, although it is likely 
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to be a two-way relationship. Interestingly, J. Szaflarski and M. Szaflarski [18] 
compared depressed pwPNES and PWE to clinically depressed patients and found 
that pwPNES reported significantly more physical role limitations. This again 
suggests that pwPNES highlight their physical symptoms and experience these as 
more disabling than patients with other health conditions. 
Critique 
This systematic review has several limitations. Whilst the abstracts of 
potential studies were screened for mentions of measures of depression, this was 
EDVHGRQWKHDXWKRU¶VNQRZOHGJHRIH[LVWLQJPHDVXUHV,WLVSRVVLEOHWKDWsuitable 
papers containing depression measures unknown to the author were missed during 
the screening process. Another weakness of the screening process was the aim to 
capture all studies measuring depression. Whilst this inclusivity was a strength of the 
review, it meant that many of the studies reviewed did not primarily investigate 
depression, but simply included a measure of it. Indeed a sizable proportion of 
studies focused on establishing criteria for the differential diagnosis of PNES and 
epilepsy. This affected the critique of the studies, as the aims of the review and the 
studies were not always comparable, partly explaining the limitations of many of the 
measures of depression used. This was an important limitation as it was unclear how 
valid some of the measures were in measuring depression as a clinical construct, a 
key aim of this review. To account for this, only studies using well-validated 
measures of depression were included in the meta-analysis. Whilst this improved the 
validity of the meta-analysis in assessing levels of depression, it may have 
introduced other sources of bias, as the selected studies were predominantly of 
lower quality. 
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One factor which may affect the findings of this review is the demographic 
differences between the PNES and epilepsy samples in many of the studies 
reviewed. Few of these studies had demographically matched samples, and most 
had a higher proportion of females in the PNES samples. It has been found that 
females with PNES may report more symptoms of depression [53, 54] and Kerr et al. 
[78] found that differences in depression between pwPNES and PWE were no longer 
significant after controlling differences for age, sex and medical co-morbidities. As 
such, the demographic differences in the samples could account for the difference in 
levels of depression between PWE and pwPNES observed in this review. However, 
it is important to note that up to 80% of pwPNES are female [2] and therefore the 
observed differences may reflect a reliable difference between populations of 
pwPNES and PWE. 
Finally, the majority of the studies included in this review were hospital-based. 
This may have allowed researchers to differentiate between epileptic and non-
epileptic seizures with greater accuracy is but is likely to have skewed the samples 
to reflect populations with elevated levels of psychopathology. However, these 
weaknesses reflect the nature of the research completed with pwPNES, rather than 
the methodology of the review and it is hard to see how they could be overcome in a 
review based on the current literature. 
The systematic nature of this review and the meta-analysis conducted are key 
strengths of this study. In particular, the absence of any publication bias suggests 
that the effect detected is reliable, with the fail-safe N suggesting 206 unpublished 
studies would need to exist to make the population effect size non-significant. 
Additionally, the use of PWE as a comparison group means that the findings are not 
simply due to the experience of seizures, but are likely to be specific to PNES, 
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identifying unique areas of difficulty and potential areas of intervention for this 
population. 
Empirical Recommendations 
The limitations highlighted in this review reflect the difficulty of conducting 
research in this area. PNES can be challenging to distinguish from epileptic seizures 
with certainty and the diagnosis is often an iterative process [30]. Researchers 
should aim to provide as much detail as possible about the diagnostic process and 
level of certainty, or clearly state the aspects for which they have no information. 
Additionally, recruiting large numbers of pwPNES is often beyond the timeframe and 
resources available to researchers, as reflected by the small sample sizes. This 
means many studies are prone to Type II errors, potentially missing important causal 
or maintaining factors for PNES. Meta-analyses can only partially address this 
weakness of the primary literature.  
Further research should explore the potential discrepancy between levels self-
reported and clinically diagnosed depression in pwPNES. Such studies could use a 
formal diagnostic process (e.g. the SCID) alongside self-report measures with well-
defined cut-off scores (e.g. the NDDI-E or the BDI-II) to explore any identified 
discrepancies in diagnosis rates. It would be important that future studies comparing 
findings between epilepsy and PNES patient groups make appropriate adjustments 
of potentially relevant between-group differences, for instance in terms of gender 
composition, age and level of education. 
Clinical Recommendations 
Clinically, there is a clear need for depression to be routinely screened for in 
both, pwPNES and PWE. Having said that, clinicians need to be aware that 
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depression may not manifest in a typical manner in pwPNES. In particular, clinicians 
should be sensitive to complaints of physical symptoms of depression and somatic 
expressions of distress in this patient group. As clinical assessments may not fully 
reflect the level of difficulty experienced by pwPNES and may lead to under-
diagnosis if used in isolation, the use of standardised self-report measures of 
depression should also be considered.  
The elevated levels of depression in pwPNES and the strength of association 
with factors such as relationships and HRQoL suggest that depression should be a 
focus for psychological treatment, which could have beneficial effects beyond the 
improvement of symptoms of depression itself.  
 
Conclusions 
The findings clearly demonstrate higher levels of depression in pwPNES than 
PWE and suggest pwPNES particularly recognise and report physical symptoms of 
depression. For pwPNES, depression seems to be particularly related to relationship 
variables, whereas in PWE, it is more closely associated to illness-related factors.  
While these findings are reasonably robust, the research available in this area 
has extensive limitations. Whilst depression is frequently measured in studies, it has 
rarely been the primary focus of research and very little information is provided about 
possible underlying cognitive processes.  
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Appendix A 
Study evaluation tool 
Methodology Critique Yes/No 
All diagnoses confirmed using video-EEG  
Explicit reference to epilepsy being excluded  
Explicit reference to a procedure to distinguish from anxiety attacks (defined as the use of 
either diagnostic criteria for conversion disorder, psychiatric assessment more generally, or 
the presence of ictal loss of/alteration in consciousness 
 
Recruitment was consecutive  
All dependent variables standardised  
Epilepsy Controls 
 
Comparable to the PNES group in WHUPVRIDJH\HDUVDQGJHQGHUGLIILQQRRI
females)  
Explicit reference to PNES being excluded  
Score 
1/7 = .14 2/7 = .29 3/7 = .43 4/7 = .57 5/7 = .71 6/7 = .86 7/7 = 1 
Sample size 
 
*RRGSDUWLFLSDQWVLQHDFKJURXS  
Moderate (26±63 participants in each group)  
Poor (<26 participants in each group)  
Very poor(<15 participants in each group)  
Overall Quality Appraisal  
+LJK\HVUDWLQJVDQGDJRRGVDPSOHVL]H  
0HGLXPµ\HV¶UDWLQJVDQGDPRGHUDWHVDPSOH  
Medium: 50±µ\HV¶UDWLQJVDQGDWOHDVWDPRGHUDWHVDPSOHVL]H  
Low: 20±µ\HV¶UDWLQJVRUDSRRUVDPSOHVL]HZHUHUDWHGDVORZTXDOLW\  
8QDFFHSWDEOHµ\HV¶UDWLQJVRUDYHU\SRRUVDPSOHVL]H  
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Appendix B 
Quality appraisal of all studies 
  
Methodology 
Quality 
assessment 
Study Analysis group  
Sample 
size Video EEG 
Epilepsy 
excluded 
Anxiety 
excluded 
Consecutive 
sampling 
Standardised 
measures 
Demographic 
match 
PNES 
excluded 
Score 
(0-1) 
Overall 
rating 
Asmussen et al. [53] Stage one & two Moderate Yes No No No Yes Yes No 0.43 Low 
Bewley, et al. [79] Stage one Poor No Yes Yes No Yes Yes Yes 0.57 Low 
Binder et al. [80] Stage one Good Yes No Yes No Yes Yes No 0.57 Medium 
Binzer et al. [81] Stage one Poor Yes Yes No Yes Yes No Yes 0.71 Low 
R. Brown et al. [65] Stage one & two Poor No Yes No No Yes Yes Yes 0.57 Low 
Cragar et al. [57] Stage one & two Moderate Yes Yes No No Yes No Yes 0.57 Medium 
Gale and Hill [82] Stage one Poor Yes Yes No No Yes No Yes 0.57 Low 
Gale et al. [54]  Stage one & two Good Yes Yes No No Yes Yes Yes 0.71 Medium 
Goldstein and Mellers [83] Stage one Poor No Yes Yes No Yes Yes Yes 0.71 Low 
Green et al. [58] Stage one & two Poor No Yes No Yes Yes No Yes 0.57 Low 
Hixson et al. [84] Stage one Poor Yes Yes No No Yes No Yes 0.57 Low 
Johnson et al. [85] Stage one Moderate Yes Yes No No Yes No No 0.43 Low 
Karakis et al. [60] Stage one & two Moderate Yes Yes No No Yes No Yes 0.57 Medium 
LaFrance et al. [59] Stage one & two Moderate No Yes No No Yes No Yes 0.43 Low 
Lawton et al. [86] Stage one Moderate No Yes No No Yes No Yes 0.43 Low 
Moore et al. [87] Stage one Poor No Yes No No Yes Yes Yes 0.57 Low 
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Myers et al. [88] Stage one Moderate Yes Yes No Yes No No Yes 0.57 Medium 
Owczarek and Jedrzejczak [89] Stage one Moderate Yes Yes No No Yes No Yes 0.57 Medium 
Prigatano and Kirlin [64] Stage one & two Poor No Yes No No No No Yes 0.29 Low 
Rawlings et al. [62] Stage one & two Moderate No Yes No No Yes No Yes 0.43 Low 
Salinksky et al. [90] Stage one Moderate No Yes No No No No Yes 0.29 Low 
Scevola et al. [91] Stage one Moderate Yes Yes Yes No Yes No Yes 0.71 Medium 
Strutt et al. [13]* Stage one Poor Yes Yes No Yes No Yes Yes 0.71 Low 
Strutt et al. [14]* Stage one Moderate Yes Yes No Yes No Yes Yes 0.71 Medium 
J. Szaflarski et al. [17]y Stage one Moderate Yes No No Yes Yes No No 0.43 Low 
J. Szaflarski and M. Szaflarski [18]y Stage one & two Good No Yes No Yes Yes No Yes 0.57 Medium 
Testa et al. [19]y Stage one Moderate Yes No No No Yes No No 0.29 Low 
Thompson et al. [55] Stage one & two Good Yes Yes No No Yes No Yes 0.57 Medium 
Tojek et al. [92] Stage one Poor Yes Yes No No Yes Yes Yes 0.71 Low 
Turner et al. [93] Stage one Poor Yes Yes Yes Yes Yes No Yes 0.86 Low 
Vanderzant et al. [94] Stage one Poor Yes Yes Yes No Yes No Yes 0.71 Low 
Wagner et al. [56] Stage one & two Poor Yes Yes No Yes Yes No Yes 0.71 Low 
Wolf et al. [95] Stage one Good Yes Yes No Yes Yes No Yes 0.71 Medium 
Yerdelen and Altintas [96] Stage one Moderate Yes Yes No No Yes No Yes 0.57 Medium 
*/ y papers using the same dataset 
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Appendix C 
Results from all studies 
Study 
Study quality 
rating 
PNES 
sample size 
Epilepsy 
sample size Depression measure (subscale) 
Mean (SD) 
(unless otherwise indicated) 
Highest scoring 
group 
Effect size 
&RKHQ¶Vd) PNES Epilepsy 
Asmussen et al. [53] Low 59 60 
BDI-II 13.3 (9.6) 11.0 (9.0) PNES 0.25 
PAI (depression) 56.46 (11.0)* 54.3 (11.2)* PNES 0.19 
Bewley, et al. [79] Low 21 21 
BDI-II 27.19 (11.37) 22.05 (10.07) PNES 0.48 
BDI-II (moderate/severe depression) 71.4% 57.1% PNES - 
Binder et al. [80] Low 70 70 MMPI-2 (depression) 68.04 (12.04)* 63.24 (11.41)* PNES 0.41 
Binzer et al. [81] Low 20 20 SCID-I (major depression) 30% 15% PNES - 
R. Brown et al. [65] Low 43 24 PHQ-9 13.0 (11.0)z 4.5 (8.75)z PNES 0.83*** 
Cragar et al. [57] Medium 29 58 MMPI-2 (depression) 74 (14.1)* 67 (11.7)* PNES 0.56 
Gale and Hill [82] Low 23 17 MMPI-2 (depression) 73.04 (15.03)* 63.59 (13.99) PNES 0.65 
Gale et al. [54] Medium 205 228 
PAI (depression) 63.4 (13.2)* 55.3 (11.6)* PNES 0.65*** 
3$,GHSUHVVLRQ 34.1% 14.0% PNES -*** 
BDI-II 17.9 (11.1) 11.8 (9.5) PNES 0.59*** 
Goldstein and Mellers 
[83] Low 25 19 HADS 5.72 (3.64) 3.58 (3.19) PNES 0.62* 
Green et al. [58] Low 23 72 
PHQ-9 13.74 (7.52) 8.65 (7.20) PNES 0.70** 
PHQ-PRGHUDWHGHSUHVVLRQ 60.9% 43.1% PNES - 
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Hixson et al. [84] Low 22 26 
BDI-II 19.06 (7.68) 13.75 (10.8) PNES 0.56 
MMPI-2 (depression) 66.58 (12.84)* 61.00 (12.93)* PNES 0.43 
Johnson et al. [85] Low 49 49 MMPI-2 (depression) 65.9 (11.56)* 62.86 (10.21)* PNES 0.28 
Karakis et al. [60] Medium 33 126 BDI 19 (11.55) 13.25 (12.09) PNES 0.48* 
LaFrance et al. [59] Low 45 32 
BDI-II 21.8 (14.9) 13.5 (10.5) PNES 0.63* 
History of mood disorder 55.6% 43.0% PNES - 
Lawton et al. [86] Low 32 37 DASS 17.0 (20.3)z 13.0 (21.29) z PNES 0.19 
Moore et al. [87] Low 19 19 HADS 6.2 (2.6) 5.8 (4.3) PNES 0.11 
Myers et al. [88] Medium 86 40 Psychiatric diagnosis (mild-moderate depression) 54.7% 32.5% PNES -* 
Owczarek and 
Jedrzejczak [89] Medium 38 36 MMPI (Depression) 60.0 (11.8)* 58.1 (12.7)* PNES 0.16 
Prigatano and Kirlin 
[64] Low 23 22 
PAI (depression) 63.59 (15.08)* 59.42 (10.35)* PNES 0.32 
Subjective rating 4.61 (3.33) 3.64 (3.4) PNES 0.29 
Rawlings et al. [62] Low 45 62 
NDDI-E 18 (5.75)z 14 (7)z PNES 0.61*** 
NDDI-E (> 15- major depression) 75.6% 43.5% PNES -** 
Salinksky et al. [90] Low 50 37 DSM-III/IV diagnosis (major depression) 46.0% 29.7% PNES - 
Scevola et al. [91] Medium 35 49 SCID-I (depression diagnosis) 34.3% 34.7% PWE - 
Strutt et al. [13]* Low 
33 35 BDI-II 24.8 (13.0) 21.6 (15.9) PNES 0.22 
32 35 DSM-IV diagnosis (depression/depression and anxiety) 68.8% 72.0% PWE - 
Strutt et al. [14]* Medium 30 51 DSM-IV diagnosis (depression/depression and anxiety) 63.3% 56.9% PNES - 
 48 
MMPI-2 (depression) - - - - 
J. Szaflarski et al. 
[17]y Low 53 53 POMS (depression/dejection) 21.6 (15.0) 13.9 (10.7) PNES 0.59** 
J. Szaflarski and M. 
Szaflarski [18]y Medium 95 99 POMS (depression/dejection >12) 66.3% 49.5% PNES -* 
Testa et al. [19]y Low 45 69 MMPI-2 (depression) 69.49 (15.69)* 65.16 (13.37)* PNES 0.3 
Thompson et al. [55] Medium 75 109 PAI (depression) 65.7 (13.4)* 59.1 (12.1)* PNES 0.52*** 
Tojek et al. [92] Low 25 33 BSI (depression) 8.28 (6.58) 6.31 (5.39) PNES 0.33 
 
Turner et al. [93] 
Low 22 21 SCID-I (major depression/depression 
and anxiety) 9.1% 19.0% PWE - 
Vanderzant et al. [94] Low 19 17 
MMPI (depression) 67.53 (13.38)* 60.41 (12.53)* PNES 0.55 
003,GHSUHVVLRQ 42.1% 23.5% PNES - 
Wagner et al. [56] Low 26 15 PAI (depression) 67.7* 56.5* PNES -o* 
Wolf et al. [95] Medium 85 91 PAI (depression) 61.54 (12.39)* 58.84 (12.59)* PNES 0.22 
Yerdelen and Altintas 
[96] Medium 54 64 SCID-I (depressive disorder) 11.2% 10.9% PNES - 
N.B.  All figures reported to a maximum of 2dp 
* p < .05 
** p <.01 
*** p <.001  
**** p < .0001 
+
 and y indicate groups of papers analysing the same dataset 
z
 median (interquartile range) 
o
 not possible to calculate 
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Appendix D 
Supplementary data tables for narrative synthesis. 
Attachment, relationships and depression 
Green et al. [58] 
Table A4 
Correlations between depression (PHQ-9) and other variables 
Category. Subscale PNES Epilepsy 
Seizure characteristics   
Duration of disorder -.05 .23 
Frequency .07 .02 
Severity .29 .36** 
Relationship quality   
Support -.26 -.06 
Conflict .52* .28* 
Depth -.32 .09 
Attachment style   
Avoidance .58** .47*** 
Anxiety .77*** .42*** 
* p <.05,   ** p < .01,   *** p < .001 
 
Table A5 
Regression analyses between depression scores  and other variables 
Group Regression step. Measure B ȕ ǻR2 
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PNES 1- demographic/seizure variables   .26 
 
Age .19 .34  
 
Gender 5.61 .29  
 
Duration of seizure disorder -.21 -.21  
 
Seizure severity .03 .13  
 2- relationship/attachment variables   .45** 
 
Conflict 3.85 .32  
 
Attachment avoidance -.11 -.02  
 
Attachment anxiety 3.82 .57*  
Epilepsy 1- demographic/seizure variables   .23** 
 
Age -.02 -.05  
 
Gender 3.58 .25*  
 
Duration of seizure disorder .08 .16  
 
Seizure severity .07 .31**  
 2- relationship/attachment variables   .16** 
 
Conflict .31 .02  
 
Attachment avoidance 3.20 .34**  
 
Attachment anxiety .80 .12  
* p <.05,   ** p < .01 
 
The LaFrance Jr. et al. [59] data is summarised under the µ+HDOWKVWDWXVTXDOLW\RI
OLIHDQGGHSUHVVLRQ¶ heading. 
Health status, quality of life and depression 
LaFrance Jr. et al. [59] 
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Table A6 
Correlations between depression (BDI-II) and other variables 
Category. Subscale PNES Epilepsy 
Seizure frequency (past month) .25 -.04 
Years with disorder -.17 -.47* 
FAD   
Problem solving .17 .01 
Communication .16 .04 
Roles .41* .30 
Affective responsiveness .11 -.05 
Affective involvement .55* .10 
Behaviour control .17 .05 
General functioning .41* .05 
QOLIE-31 -.73* -.75* 
* p < .01 
 
A regression analysis was run using HRQoL as the dependent variable. Seizure-
related variables were used in step 1 and depression was entered as the sole 
variable in step 2: epilepsy, ȕ= .7, p <.01ǻR2 = .4; PNES, ȕ= -.7, p < .01ǻR2 = .5. 
Karakis et al. [60] 
Measures with significant differences between groups were entered into a regression 
analysis. The data for depression (BDI) was: epilepsy, not reported; PNES, ȕ= -.85, 
p ǻR2 = .55.  
Rawlings et al. [62] 
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Table A7 
Correlations between HRQoL and other variables 
Category. Measure PNES Epilepsy 
Seizure characteristics   
Duration .06 -.06 
Frequency -.22 -.38** 
Severity -.16 -.29* 
Depression (NDDI-E) -.54*** -.56*** 
* p < .05,   ** p < .01,   *** p < .001 
 
J. Szaflarski and M. Szaflarski [18] 
HRQoL was measured using the Short-Form-36 (SF-36). 
Table A8 
Mean (SD) scores on SF-36 for depressed participants 
SF-36 subscale PNESa Epilepsy 
Physical functioning 50.79 (24.58) 73.04 (21.94) 
Role limitation: physicalb 13.89 (26.10) 31.12 (38.71) 
Role limitation: emotional 29.59 (37.45) 42.18 (39.02) 
Energy/fatigue 24.78 (15.96) 38.43 (20.67) 
Emotional wellbeing 39.29 (19.78) 49.43 (17.66) 
Social functioning 30.89 (25.69) 48.57 (28.95) 
Pain 45.05 (26.97) 58.47 (24.63) 
General health 38.84 (20.85) 45.61 (19.81) 
CATASTROPHISING IN PATIENTS WITH PSYCHOGENIC NON-EPILEPTIC SEIZURES 53 
NB. A cut-off of > 12 on the POMS was used to identify participants with 
depression. 
a
 All scores significantly different from PWE 
b
 The interaction between diagnosis and depression was significant in a 
regression model   
 
Table A9 
Mean (SD) SF-36 scores for all participants 
SF-36 subscale Clinical depression PNES Epilepsy 
Physical functioning 71.58 (27.17) 56.40 (25.99)* 77.67 (22.65) 
Role limitation: physical 44.39 (40.26) 18.16 (28.82)* 47.47 (41.73) 
Role limitation: emotional 38.90 (39.80) 43.15 (42.39) 59.83 (39.51)* 
Energy/fatigue 40.12 (21.08) 28.54 (18.09)* 45.57 (21.00) 
Emotional wellbeing 46.26 (20.83) 50.14 (24.18) 61.43 (20.11)* 
Social functioning 57.16 (27.67) 37.60 (30.47)* 60.89 (29.03) 
Pain 58.84 (26.74) 48.83 (28.39)* 65.80 (24.44) 
General health 52.94 (22.98) 44.23 (22.06)* 53.48 (22.04) 
NB. Higher scores = better HRQoL 
 
Cognitive and emotional functioning and depression 
R. Brown et al. [65] 
PwPNES were separated into cluster one (high alexithymia and emotional 
dysregulation) and cluster two (the remainder of the sample).  
Table A10 
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Mean (SD) depression scores and statistical comparisons between groups. 
Group Cluster one PNES Cluster two PNES Epilepsy 
Cluster one PNES - ns p  
Cluster two PNES - - p  
Mean (SD) 16.0 (12.0) 10.0 (9.5) 4.5 (8.75) 
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Prigatano et al. [64] 
Participants rated their memory, word finding and depression and then completed 
standardised measures including the PAI (depression). Memory was assessed with 
the Rey Auditory Verbal Learning Test (RAVLT), Brief Visuospatial Memory Test-
Revised (BVMT-R), and BNI Screen for Higher Cerebral Functions Memory subscale 
(BNIS). Word finding was assessed using the Boston Naming Test (BNT). 
Table A11 
Correlations between depression and other variables 
 PNES Epilepsy 
Patient-rated 
depression 
PAI 
depression 
Patient-rated 
depression 
PAI 
depression 
Patient rated      
Depression - .74** - .85** 
Memory .56** .42* .41 .49* 
Word-finding difficulty .43** .25 .55** .49* 
Standardised measure     
PAI depression .74** - .85** - 
RAVLT delayed recall -.42* -.32 -.2 -.34 
BVMT-R delayed recall -.25 -.29 .02 .07 
BNIS memory subscale -.05 -.02 -.14 -.27 
BNT .07 -.04 -.40 -.37 
BNIS affect subscale -.17 -.17 -.02 -.07 
* p .05,   ** p  .01 
 
 
